FrançaisAre analysts right about MetLife (MET)?
📈 See the interactive version (live chart) →
Historical analyst accuracy
For MetLife, we replayed every analyst price target of the past 12 months and measured the real outcome: 36% were profitable, average return +12% (192 calls). At 3 months: +4% average return (45% profitable). The higher the %, the more often analysts were right on this stock.
Most reliable analysts on this stock (past track record)
Their past track record on this stock (targets replayed against real prices) — not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Morgan Stanley | 40 | 42% | +18% |
| Wells Fargo | 21 | 33% | +12% |
| Barclays | 18 | 17% | +5% |
| Citigroup | 13 | 23% | -1% |
| JP Morgan | 12 | 42% | +13% |
Valuation
Is MetLife overvalued, and is it a good time to buy MetLife right now? If you're wondering, here's a recap to make up your own mind: MetLife's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price ÷ earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects — but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | MetLife | Sector median (Financials) |
|---|---|---|
| P/E | 18.5 | 14.0 |
| Forward P/E | 8.8 | 11.1 |
| Net margin | 5% | 24% |
👉 MetLife trades above its sector median (18.5 vs 14.0) — the market expects higher growth; watch out for disappointment.
📖 P/E, PEG, margin…: see the glossary
💵 Dividend : MetLife pays about $2.30/share/yr → 2.63% yield. what is this?
Frequently asked questions
Is MetLife a buy right now?
The analyst consensus on MetLife (MET) is "Buy" (41 bullish, 0 bearish calls over 12 months). This is not advice: historically, 36% of their targets on this stock turned out profitable over 1 year.
What is MetLife's price target?
The median 12-month price target is $104 (+8% vs $96.25), ranging from $90.00 to $111 (12 analysts).
Are analysts accurate on MetLife?
Over 1 year, 36% of analyst targets on MetLife were profitable, for an average return of +12% (across 192 timestamped calls). This is JPI Invest's accuracy metric.
What is the MetLife stock forecast?
Analysts target a median of $104 within 12 months, i.e. +8% vs the current price. The most bullish targets $111, the most cautious $90.00.
What is the MetLife stock forecast for 2026 or long term (2030)?
Note: analyst targets are 12-month (median $104, +8%), NOT 2030. No reliable 5-10 year price forecast exists (« 2030 prediction » models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (36%), and the stock's past trajectory.
Is MetLife overvalued?
Its P/E is 18.5, forward P/E 8.8. A forward P/E lower than the current P/E means earnings are expected to grow.
📊 See the full interactive analysis of MetLife →
What is JPI Invest?
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
- 🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
- 🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
- 💬 AI assistant: ask anything about any stock, with the numbers
- 📊 Portfolio tracking + 🔔 price alerts by email
⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.